RESPONSIBILITIES OF INSTITUTION. The Institution shall: provide passwords and other confidential Authentication Information only to Authorised Users and take reasonable steps to prevent Authorised Users from providing such Authentication Information to anyone else; provide to the Publisher lists of valid IP addresses for the purpose of managing access to the Licensed Material and update those lists regularly as agreed by the parties from time to time; use reasonable efforts to ensure that only Authorised Users are permitted access to the Licensed Material; inform the Authorised Users about the conditions of use of the Licensed Material provided for in this Licence and to the extent that such terms apply to them, use reasonable efforts to ensure that all Authorised Users are made aware of and undertake to abide by the terms of this Licence; and configure the computer system through which the Licensed Material used by the Institution and Authorised Users, and put in place procedures, in accordance with reasonably appropriate accepted standards, for the purpose of preventing access to the Licensed Material by any person other than an Authorised User. The Institution shall use reasonable efforts to monitor compliance with the terms of this Licence and shall promptly notify the Publisher, providing full particulars (to the extent that it is not prohibited by law or contractual obligation from doing so), on becoming aware of any of the following: any unauthorised access to or use of the Licensed Material or unauthorised use of Authentication Information; or any act by an Authorised User which gives rise to a breach of this Licence. As soon as the Institution is aware of any breach of the terms of this Licence, the Institution shall: take reasonable steps to investigate such breach for the purpose of ensuring that the relevant activity ceases and preventing any recurrence; and if the Institution considers this appropriate, take steps against the individual concerned in accordance with the Institution’s disciplinary procedure but the Institution shall not have any other liability for any breach relating to the security of the Secure Network or use by Authorised Users of any Licensed Material.
RESPONSIBILITIES OF INSTITUTION. 1. INSTITUTION shall identify in writing the educational goals and objectives to be attained during RESIDENT’s clinical experience at DEPARTMENT and shall attach same hereto as Attachment A.
RESPONSIBILITIES OF INSTITUTION. 8.1 The Institution shall:
RESPONSIBILITIES OF INSTITUTION. In accordance with the terms and conditions of this Agreement and any Program-specific curriculum provided to Institution by FIU, Institution agrees to provide an educational/professional and/or other experiences for Students in connection with the Program, and Institution shall:
RESPONSIBILITIES OF INSTITUTION. UVM Medical Center, as the sponsor for GME training Programs, acknowledges and agrees to responsibilities for:
RESPONSIBILITIES OF INSTITUTION. A. Institution shall have the responsibilities and shall perform the Services as specified in individual Task Orders. A Task Order may require Institution to co-ordinate with Novartis and/or other parties in performing the Services.
RESPONSIBILITIES OF INSTITUTION. 3.1 Institution shall have the following responsibilities under this Agreement.
RESPONSIBILITIES OF INSTITUTION. 1. INSTITUTION shall provide qualified preceptors and a structured educational experience to RESIDENT pursuant to ACGME standards. The individual assigned by INSTITUTION to assume administrative, educational, and supervisory responsibility for RESIDENT’s clinical experience is ____________________________________________________.
RESPONSIBILITIES OF INSTITUTION. 3.1 Institution shall create bibliographic records and related data for entering information into WorldCat consistent with the Guidelines maintained by OCLC and its advisory groups.
RESPONSIBILITIES OF INSTITUTION. II.1. Institution shall perform the Study in compliance with all laws and regulations that apply to the Study (“Applicable Law”), including, but not limited to 21 CFR Parts 50 (Protection of Human Subjects), 56 (Institutional Review Boards), and 42 CFR Parts 160 and 164 (the HIPAA Privacy Rule). Neither Party nor the Principal Investigators shall use any biological materials for any purposes not allowed by the protocol, the informed consent document, and the HIPAA authorization signed by the subject providing the material. Any biological materials remaining at the end of the Study shall be destroyed or handled consistent with the informed consent form or HIPAA authorization under which they were obtained.
